Global RNA Therapeutics and Vaccines Market Research Report 2025(Status and Outlook)
Report Overview
RNA Therapeutics and Vaccines refer to a rapidly advancing field in the pharmaceutical and biotechnology industries that focuses on the development and application of RNA-based treatments and vaccines. This innovative approach leverages the potential of RNA molecules to modulate gene expression, correct genetic disorders, or stimulate an immune response against specific pathogens. RNA therapeutics encompass a variety of applications, including the use of small interfering RNA (siRNA), messenger RNA (mRNA), and antisense oligonucleotides (ASOs) to target and silence or activate specific genes, thereby treating diseases at the genetic level. In the context of vaccines, RNA-based vaccines, such as mRNA vaccines, have shown promise in inducing robust immune responses by introducing a harmless piece of the pathogen's genetic code, which instructs cells to produce a protein that triggers the immune system to recognize and fight the actual pathogen. This technology has been particularly notable for its role in the development of COVID-19 vaccines, demonstrating the potential of RNA-based approaches to address both chronic and acute health challenges.
In 2024, the global RNA Therapeutics and Vaccines market is projected to reach approximately USD xx Million, with expectations to grow at a compound annual growth rate (CAGR) of around xx between 2024 and 2033.
This report provides a deep insight into the global RNA Therapeutics and Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNA Therapeutics and Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNA Therapeutics and Vaccines market in any manner.
Global RNA Therapeutics and Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
BioNTech (Pfizer)
Sanofi
Novartis
CureVac
CSL
Arrowhead Pharmaceuticals
Alnylam Pharmaceuticals
GlaxoSmithKline (GSK)
Ionis Pharmaceuticals
Regulus Therapeutics
Roche
AstraZeneca
Sarepta Therapeutics
Orna Therapeutics
Market Segmentation (by Type)
mRNA (messenger RNA) Therapeutics
siRNA (small interfering RNA) Therapeutics
Antisense Oligonucleotide Therapeutics
Market Segmentation (by Application)
Hospitals
Research Institutions
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the RNA Therapeutics and Vaccines Market
Overview of the regional outlook of the RNA Therapeutics and Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNA Therapeutics and Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of RNA Therapeutics and Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
RNA Therapeutics and Vaccines refer to a rapidly advancing field in the pharmaceutical and biotechnology industries that focuses on the development and application of RNA-based treatments and vaccines. This innovative approach leverages the potential of RNA molecules to modulate gene expression, correct genetic disorders, or stimulate an immune response against specific pathogens. RNA therapeutics encompass a variety of applications, including the use of small interfering RNA (siRNA), messenger RNA (mRNA), and antisense oligonucleotides (ASOs) to target and silence or activate specific genes, thereby treating diseases at the genetic level. In the context of vaccines, RNA-based vaccines, such as mRNA vaccines, have shown promise in inducing robust immune responses by introducing a harmless piece of the pathogen's genetic code, which instructs cells to produce a protein that triggers the immune system to recognize and fight the actual pathogen. This technology has been particularly notable for its role in the development of COVID-19 vaccines, demonstrating the potential of RNA-based approaches to address both chronic and acute health challenges.
In 2024, the global RNA Therapeutics and Vaccines market is projected to reach approximately USD xx Million, with expectations to grow at a compound annual growth rate (CAGR) of around xx between 2024 and 2033.
This report provides a deep insight into the global RNA Therapeutics and Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNA Therapeutics and Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNA Therapeutics and Vaccines market in any manner.
Global RNA Therapeutics and Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
BioNTech (Pfizer)
Sanofi
Novartis
CureVac
CSL
Arrowhead Pharmaceuticals
Alnylam Pharmaceuticals
GlaxoSmithKline (GSK)
Ionis Pharmaceuticals
Regulus Therapeutics
Roche
AstraZeneca
Sarepta Therapeutics
Orna Therapeutics
Market Segmentation (by Type)
mRNA (messenger RNA) Therapeutics
siRNA (small interfering RNA) Therapeutics
Antisense Oligonucleotide Therapeutics
Market Segmentation (by Application)
Hospitals
Research Institutions
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the RNA Therapeutics and Vaccines Market
Overview of the regional outlook of the RNA Therapeutics and Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNA Therapeutics and Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of RNA Therapeutics and Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of RNA Therapeutics and Vaccines
1.2 Key Market Segments
1.2.1 RNA Therapeutics and Vaccines Segment by Type
1.2.2 RNA Therapeutics and Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNA THERAPEUTICS AND VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RNA Therapeutics and Vaccines Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global RNA Therapeutics and Vaccines Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNA THERAPEUTICS AND VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global RNA Therapeutics and Vaccines Product Life Cycle
3.3 Global RNA Therapeutics and Vaccines Sales by Manufacturers (2020-2025)
3.4 Global RNA Therapeutics and Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 RNA Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global RNA Therapeutics and Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 RNA Therapeutics and Vaccines Market Competitive Situation and Trends
3.8.1 RNA Therapeutics and Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest RNA Therapeutics and Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RNA THERAPEUTICS AND VACCINES INDUSTRY CHAIN ANALYSIS
4.1 RNA Therapeutics and Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RNA THERAPEUTICS AND VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global RNA Therapeutics and Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to RNA Therapeutics and Vaccines Market
5.7 ESG Ratings of Leading Companies
6 RNA THERAPEUTICS AND VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNA Therapeutics and Vaccines Sales Market Share by Type (2020-2025)
6.3 Global RNA Therapeutics and Vaccines Market Size Market Share by Type (2020-2025)
6.4 Global RNA Therapeutics and Vaccines Price by Type (2020-2025)
7 RNA THERAPEUTICS AND VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNA Therapeutics and Vaccines Market Sales by Application (2020-2025)
7.3 Global RNA Therapeutics and Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global RNA Therapeutics and Vaccines Sales Growth Rate by Application (2020-2025)
8 RNA THERAPEUTICS AND VACCINES MARKET SALES BY REGION
8.1 Global RNA Therapeutics and Vaccines Sales by Region
8.1.1 Global RNA Therapeutics and Vaccines Sales by Region
8.1.2 Global RNA Therapeutics and Vaccines Sales Market Share by Region
8.2 Global RNA Therapeutics and Vaccines Market Size by Region
8.2.1 Global RNA Therapeutics and Vaccines Market Size by Region
8.2.2 Global RNA Therapeutics and Vaccines Market Size Market Share by Region
8.3 North America
8.3.1 North America RNA Therapeutics and Vaccines Sales by Country
8.3.2 North America RNA Therapeutics and Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe RNA Therapeutics and Vaccines Sales by Country
8.4.2 Europe RNA Therapeutics and Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific RNA Therapeutics and Vaccines Sales by Region
8.5.2 Asia Pacific RNA Therapeutics and Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America RNA Therapeutics and Vaccines Sales by Country
8.6.2 South America RNA Therapeutics and Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa RNA Therapeutics and Vaccines Sales by Region
8.7.2 Middle East and Africa RNA Therapeutics and Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RNA THERAPEUTICS AND VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of RNA Therapeutics and Vaccines by Region(2020-2025)
9.2 Global RNA Therapeutics and Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America RNA Therapeutics and Vaccines Production
9.4.1 North America RNA Therapeutics and Vaccines Production Growth Rate (2020-2025)
9.4.2 North America RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe RNA Therapeutics and Vaccines Production
9.5.1 Europe RNA Therapeutics and Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan RNA Therapeutics and Vaccines Production (2020-2025)
9.6.1 Japan RNA Therapeutics and Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China RNA Therapeutics and Vaccines Production (2020-2025)
9.7.1 China RNA Therapeutics and Vaccines Production Growth Rate (2020-2025)
9.7.2 China RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Moderna
10.1.1 Moderna Basic Information
10.1.2 Moderna RNA Therapeutics and Vaccines Product Overview
10.1.3 Moderna RNA Therapeutics and Vaccines Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 BioNTech (Pfizer)
10.2.1 BioNTech (Pfizer) Basic Information
10.2.2 BioNTech (Pfizer) RNA Therapeutics and Vaccines Product Overview
10.2.3 BioNTech (Pfizer) RNA Therapeutics and Vaccines Product Market Performance
10.2.4 BioNTech (Pfizer) Business Overview
10.2.5 BioNTech (Pfizer) SWOT Analysis
10.2.6 BioNTech (Pfizer) Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi RNA Therapeutics and Vaccines Product Overview
10.3.3 Sanofi RNA Therapeutics and Vaccines Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis RNA Therapeutics and Vaccines Product Overview
10.4.3 Novartis RNA Therapeutics and Vaccines Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 CureVac
10.5.1 CureVac Basic Information
10.5.2 CureVac RNA Therapeutics and Vaccines Product Overview
10.5.3 CureVac RNA Therapeutics and Vaccines Product Market Performance
10.5.4 CureVac Business Overview
10.5.5 CureVac Recent Developments
10.6 CSL
10.6.1 CSL Basic Information
10.6.2 CSL RNA Therapeutics and Vaccines Product Overview
10.6.3 CSL RNA Therapeutics and Vaccines Product Market Performance
10.6.4 CSL Business Overview
10.6.5 CSL Recent Developments
10.7 Arrowhead Pharmaceuticals
10.7.1 Arrowhead Pharmaceuticals Basic Information
10.7.2 Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
10.7.3 Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Product Market Performance
10.7.4 Arrowhead Pharmaceuticals Business Overview
10.7.5 Arrowhead Pharmaceuticals Recent Developments
10.8 Alnylam Pharmaceuticals
10.8.1 Alnylam Pharmaceuticals Basic Information
10.8.2 Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
10.8.3 Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Product Market Performance
10.8.4 Alnylam Pharmaceuticals Business Overview
10.8.5 Alnylam Pharmaceuticals Recent Developments
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Basic Information
10.9.2 GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Product Overview
10.9.3 GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Product Market Performance
10.9.4 GlaxoSmithKline (GSK) Business Overview
10.9.5 GlaxoSmithKline (GSK) Recent Developments
10.10 Ionis Pharmaceuticals
10.10.1 Ionis Pharmaceuticals Basic Information
10.10.2 Ionis Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
10.10.3 Ionis Pharmaceuticals RNA Therapeutics and Vaccines Product Market Performance
10.10.4 Ionis Pharmaceuticals Business Overview
10.10.5 Ionis Pharmaceuticals Recent Developments
10.11 Regulus Therapeutics
10.11.1 Regulus Therapeutics Basic Information
10.11.2 Regulus Therapeutics RNA Therapeutics and Vaccines Product Overview
10.11.3 Regulus Therapeutics RNA Therapeutics and Vaccines Product Market Performance
10.11.4 Regulus Therapeutics Business Overview
10.11.5 Regulus Therapeutics Recent Developments
10.12 Roche
10.12.1 Roche Basic Information
10.12.2 Roche RNA Therapeutics and Vaccines Product Overview
10.12.3 Roche RNA Therapeutics and Vaccines Product Market Performance
10.12.4 Roche Business Overview
10.12.5 Roche Recent Developments
10.13 AstraZeneca
10.13.1 AstraZeneca Basic Information
10.13.2 AstraZeneca RNA Therapeutics and Vaccines Product Overview
10.13.3 AstraZeneca RNA Therapeutics and Vaccines Product Market Performance
10.13.4 AstraZeneca Business Overview
10.13.5 AstraZeneca Recent Developments
10.14 Sarepta Therapeutics
10.14.1 Sarepta Therapeutics Basic Information
10.14.2 Sarepta Therapeutics RNA Therapeutics and Vaccines Product Overview
10.14.3 Sarepta Therapeutics RNA Therapeutics and Vaccines Product Market Performance
10.14.4 Sarepta Therapeutics Business Overview
10.14.5 Sarepta Therapeutics Recent Developments
10.15 Orna Therapeutics
10.15.1 Orna Therapeutics Basic Information
10.15.2 Orna Therapeutics RNA Therapeutics and Vaccines Product Overview
10.15.3 Orna Therapeutics RNA Therapeutics and Vaccines Product Market Performance
10.15.4 Orna Therapeutics Business Overview
10.15.5 Orna Therapeutics Recent Developments
11 RNA THERAPEUTICS AND VACCINES MARKET FORECAST BY REGION
11.1 Global RNA Therapeutics and Vaccines Market Size Forecast
11.2 Global RNA Therapeutics and Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe RNA Therapeutics and Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific RNA Therapeutics and Vaccines Market Size Forecast by Region
11.2.4 South America RNA Therapeutics and Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of RNA Therapeutics and Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global RNA Therapeutics and Vaccines Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of RNA Therapeutics and Vaccines by Type (2026-2033)
12.1.2 Global RNA Therapeutics and Vaccines Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of RNA Therapeutics and Vaccines by Type (2026-2033)
12.2 Global RNA Therapeutics and Vaccines Market Forecast by Application (2026-2033)
12.2.1 Global RNA Therapeutics and Vaccines Sales (K MT) Forecast by Application
12.2.2 Global RNA Therapeutics and Vaccines Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of RNA Therapeutics and Vaccines
1.2 Key Market Segments
1.2.1 RNA Therapeutics and Vaccines Segment by Type
1.2.2 RNA Therapeutics and Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNA THERAPEUTICS AND VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RNA Therapeutics and Vaccines Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global RNA Therapeutics and Vaccines Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNA THERAPEUTICS AND VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global RNA Therapeutics and Vaccines Product Life Cycle
3.3 Global RNA Therapeutics and Vaccines Sales by Manufacturers (2020-2025)
3.4 Global RNA Therapeutics and Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 RNA Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global RNA Therapeutics and Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 RNA Therapeutics and Vaccines Market Competitive Situation and Trends
3.8.1 RNA Therapeutics and Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest RNA Therapeutics and Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RNA THERAPEUTICS AND VACCINES INDUSTRY CHAIN ANALYSIS
4.1 RNA Therapeutics and Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RNA THERAPEUTICS AND VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global RNA Therapeutics and Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to RNA Therapeutics and Vaccines Market
5.7 ESG Ratings of Leading Companies
6 RNA THERAPEUTICS AND VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNA Therapeutics and Vaccines Sales Market Share by Type (2020-2025)
6.3 Global RNA Therapeutics and Vaccines Market Size Market Share by Type (2020-2025)
6.4 Global RNA Therapeutics and Vaccines Price by Type (2020-2025)
7 RNA THERAPEUTICS AND VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNA Therapeutics and Vaccines Market Sales by Application (2020-2025)
7.3 Global RNA Therapeutics and Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global RNA Therapeutics and Vaccines Sales Growth Rate by Application (2020-2025)
8 RNA THERAPEUTICS AND VACCINES MARKET SALES BY REGION
8.1 Global RNA Therapeutics and Vaccines Sales by Region
8.1.1 Global RNA Therapeutics and Vaccines Sales by Region
8.1.2 Global RNA Therapeutics and Vaccines Sales Market Share by Region
8.2 Global RNA Therapeutics and Vaccines Market Size by Region
8.2.1 Global RNA Therapeutics and Vaccines Market Size by Region
8.2.2 Global RNA Therapeutics and Vaccines Market Size Market Share by Region
8.3 North America
8.3.1 North America RNA Therapeutics and Vaccines Sales by Country
8.3.2 North America RNA Therapeutics and Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe RNA Therapeutics and Vaccines Sales by Country
8.4.2 Europe RNA Therapeutics and Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific RNA Therapeutics and Vaccines Sales by Region
8.5.2 Asia Pacific RNA Therapeutics and Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America RNA Therapeutics and Vaccines Sales by Country
8.6.2 South America RNA Therapeutics and Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa RNA Therapeutics and Vaccines Sales by Region
8.7.2 Middle East and Africa RNA Therapeutics and Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RNA THERAPEUTICS AND VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of RNA Therapeutics and Vaccines by Region(2020-2025)
9.2 Global RNA Therapeutics and Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America RNA Therapeutics and Vaccines Production
9.4.1 North America RNA Therapeutics and Vaccines Production Growth Rate (2020-2025)
9.4.2 North America RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe RNA Therapeutics and Vaccines Production
9.5.1 Europe RNA Therapeutics and Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan RNA Therapeutics and Vaccines Production (2020-2025)
9.6.1 Japan RNA Therapeutics and Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China RNA Therapeutics and Vaccines Production (2020-2025)
9.7.1 China RNA Therapeutics and Vaccines Production Growth Rate (2020-2025)
9.7.2 China RNA Therapeutics and Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Moderna
10.1.1 Moderna Basic Information
10.1.2 Moderna RNA Therapeutics and Vaccines Product Overview
10.1.3 Moderna RNA Therapeutics and Vaccines Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 BioNTech (Pfizer)
10.2.1 BioNTech (Pfizer) Basic Information
10.2.2 BioNTech (Pfizer) RNA Therapeutics and Vaccines Product Overview
10.2.3 BioNTech (Pfizer) RNA Therapeutics and Vaccines Product Market Performance
10.2.4 BioNTech (Pfizer) Business Overview
10.2.5 BioNTech (Pfizer) SWOT Analysis
10.2.6 BioNTech (Pfizer) Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi RNA Therapeutics and Vaccines Product Overview
10.3.3 Sanofi RNA Therapeutics and Vaccines Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis RNA Therapeutics and Vaccines Product Overview
10.4.3 Novartis RNA Therapeutics and Vaccines Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 CureVac
10.5.1 CureVac Basic Information
10.5.2 CureVac RNA Therapeutics and Vaccines Product Overview
10.5.3 CureVac RNA Therapeutics and Vaccines Product Market Performance
10.5.4 CureVac Business Overview
10.5.5 CureVac Recent Developments
10.6 CSL
10.6.1 CSL Basic Information
10.6.2 CSL RNA Therapeutics and Vaccines Product Overview
10.6.3 CSL RNA Therapeutics and Vaccines Product Market Performance
10.6.4 CSL Business Overview
10.6.5 CSL Recent Developments
10.7 Arrowhead Pharmaceuticals
10.7.1 Arrowhead Pharmaceuticals Basic Information
10.7.2 Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
10.7.3 Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Product Market Performance
10.7.4 Arrowhead Pharmaceuticals Business Overview
10.7.5 Arrowhead Pharmaceuticals Recent Developments
10.8 Alnylam Pharmaceuticals
10.8.1 Alnylam Pharmaceuticals Basic Information
10.8.2 Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
10.8.3 Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Product Market Performance
10.8.4 Alnylam Pharmaceuticals Business Overview
10.8.5 Alnylam Pharmaceuticals Recent Developments
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Basic Information
10.9.2 GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Product Overview
10.9.3 GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Product Market Performance
10.9.4 GlaxoSmithKline (GSK) Business Overview
10.9.5 GlaxoSmithKline (GSK) Recent Developments
10.10 Ionis Pharmaceuticals
10.10.1 Ionis Pharmaceuticals Basic Information
10.10.2 Ionis Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
10.10.3 Ionis Pharmaceuticals RNA Therapeutics and Vaccines Product Market Performance
10.10.4 Ionis Pharmaceuticals Business Overview
10.10.5 Ionis Pharmaceuticals Recent Developments
10.11 Regulus Therapeutics
10.11.1 Regulus Therapeutics Basic Information
10.11.2 Regulus Therapeutics RNA Therapeutics and Vaccines Product Overview
10.11.3 Regulus Therapeutics RNA Therapeutics and Vaccines Product Market Performance
10.11.4 Regulus Therapeutics Business Overview
10.11.5 Regulus Therapeutics Recent Developments
10.12 Roche
10.12.1 Roche Basic Information
10.12.2 Roche RNA Therapeutics and Vaccines Product Overview
10.12.3 Roche RNA Therapeutics and Vaccines Product Market Performance
10.12.4 Roche Business Overview
10.12.5 Roche Recent Developments
10.13 AstraZeneca
10.13.1 AstraZeneca Basic Information
10.13.2 AstraZeneca RNA Therapeutics and Vaccines Product Overview
10.13.3 AstraZeneca RNA Therapeutics and Vaccines Product Market Performance
10.13.4 AstraZeneca Business Overview
10.13.5 AstraZeneca Recent Developments
10.14 Sarepta Therapeutics
10.14.1 Sarepta Therapeutics Basic Information
10.14.2 Sarepta Therapeutics RNA Therapeutics and Vaccines Product Overview
10.14.3 Sarepta Therapeutics RNA Therapeutics and Vaccines Product Market Performance
10.14.4 Sarepta Therapeutics Business Overview
10.14.5 Sarepta Therapeutics Recent Developments
10.15 Orna Therapeutics
10.15.1 Orna Therapeutics Basic Information
10.15.2 Orna Therapeutics RNA Therapeutics and Vaccines Product Overview
10.15.3 Orna Therapeutics RNA Therapeutics and Vaccines Product Market Performance
10.15.4 Orna Therapeutics Business Overview
10.15.5 Orna Therapeutics Recent Developments
11 RNA THERAPEUTICS AND VACCINES MARKET FORECAST BY REGION
11.1 Global RNA Therapeutics and Vaccines Market Size Forecast
11.2 Global RNA Therapeutics and Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe RNA Therapeutics and Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific RNA Therapeutics and Vaccines Market Size Forecast by Region
11.2.4 South America RNA Therapeutics and Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of RNA Therapeutics and Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global RNA Therapeutics and Vaccines Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of RNA Therapeutics and Vaccines by Type (2026-2033)
12.1.2 Global RNA Therapeutics and Vaccines Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of RNA Therapeutics and Vaccines by Type (2026-2033)
12.2 Global RNA Therapeutics and Vaccines Market Forecast by Application (2026-2033)
12.2.1 Global RNA Therapeutics and Vaccines Sales (K MT) Forecast by Application
12.2.2 Global RNA Therapeutics and Vaccines Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNA Therapeutics and Vaccines Market Size Comparison by Region (M USD)
Table 5. Global RNA Therapeutics and Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global RNA Therapeutics and Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 7. Global RNA Therapeutics and Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global RNA Therapeutics and Vaccines Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics and Vaccines as of 2024)
Table 10. Global Market RNA Therapeutics and Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global RNA Therapeutics and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. RNA Therapeutics and Vaccines Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global RNA Therapeutics and Vaccines Sales by Type (K MT)
Table 26. Global RNA Therapeutics and Vaccines Market Size by Type (M USD)
Table 27. Global RNA Therapeutics and Vaccines Sales (K MT) by Type (2020-2025)
Table 28. Global RNA Therapeutics and Vaccines Sales Market Share by Type (2020-2025)
Table 29. Global RNA Therapeutics and Vaccines Market Size (M USD) by Type (2020-2025)
Table 30. Global RNA Therapeutics and Vaccines Market Size Share by Type (2020-2025)
Table 31. Global RNA Therapeutics and Vaccines Price (USD/KG) by Type (2020-2025)
Table 32. Global RNA Therapeutics and Vaccines Sales (K MT) by Application
Table 33. Global RNA Therapeutics and Vaccines Market Size by Application
Table 34. Global RNA Therapeutics and Vaccines Sales by Application (2020-2025) & (K MT)
Table 35. Global RNA Therapeutics and Vaccines Sales Market Share by Application (2020-2025)
Table 36. Global RNA Therapeutics and Vaccines Market Size by Application (2020-2025) & (M USD)
Table 37. Global RNA Therapeutics and Vaccines Market Share by Application (2020-2025)
Table 38. Global RNA Therapeutics and Vaccines Sales Growth Rate by Application (2020-2025)
Table 39. Global RNA Therapeutics and Vaccines Sales by Region (2020-2025) & (K MT)
Table 40. Global RNA Therapeutics and Vaccines Sales Market Share by Region (2020-2025)
Table 41. Global RNA Therapeutics and Vaccines Market Size by Region (2020-2025) & (M USD)
Table 42. Global RNA Therapeutics and Vaccines Market Size Market Share by Region (2020-2025)
Table 43. North America RNA Therapeutics and Vaccines Sales by Country (2020-2025) & (K MT)
Table 44. North America RNA Therapeutics and Vaccines Market Size by Country (2020-2025) & (M USD)
Table 45. Europe RNA Therapeutics and Vaccines Sales by Country (2020-2025) & (K MT)
Table 46. Europe RNA Therapeutics and Vaccines Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific RNA Therapeutics and Vaccines Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific RNA Therapeutics and Vaccines Market Size by Region (2020-2025) & (M USD)
Table 49. South America RNA Therapeutics and Vaccines Sales by Country (2020-2025) & (K MT)
Table 50. South America RNA Therapeutics and Vaccines Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa RNA Therapeutics and Vaccines Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa RNA Therapeutics and Vaccines Market Size by Region (2020-2025) & (M USD)
Table 53. Global RNA Therapeutics and Vaccines Production (K MT) by Region(2020-2025)
Table 54. Global RNA Therapeutics and Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 55. Global RNA Therapeutics and Vaccines Revenue Market Share by Region (2020-2025)
Table 56. Global RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Moderna Basic Information
Table 62. Moderna RNA Therapeutics and Vaccines Product Overview
Table 63. Moderna RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Moderna Business Overview
Table 65. Moderna SWOT Analysis
Table 66. Moderna Recent Developments
Table 67. BioNTech (Pfizer) Basic Information
Table 68. BioNTech (Pfizer) RNA Therapeutics and Vaccines Product Overview
Table 69. BioNTech (Pfizer) RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. BioNTech (Pfizer) Business Overview
Table 71. BioNTech (Pfizer) SWOT Analysis
Table 72. BioNTech (Pfizer) Recent Developments
Table 73. Sanofi Basic Information
Table 74. Sanofi RNA Therapeutics and Vaccines Product Overview
Table 75. Sanofi RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Sanofi Business Overview
Table 77. Sanofi SWOT Analysis
Table 78. Sanofi Recent Developments
Table 79. Novartis Basic Information
Table 80. Novartis RNA Therapeutics and Vaccines Product Overview
Table 81. Novartis RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. CureVac Basic Information
Table 85. CureVac RNA Therapeutics and Vaccines Product Overview
Table 86. CureVac RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. CureVac Business Overview
Table 88. CureVac Recent Developments
Table 89. CSL Basic Information
Table 90. CSL RNA Therapeutics and Vaccines Product Overview
Table 91. CSL RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. CSL Business Overview
Table 93. CSL Recent Developments
Table 94. Arrowhead Pharmaceuticals Basic Information
Table 95. Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
Table 96. Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Arrowhead Pharmaceuticals Business Overview
Table 98. Arrowhead Pharmaceuticals Recent Developments
Table 99. Alnylam Pharmaceuticals Basic Information
Table 100. Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
Table 101. Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Alnylam Pharmaceuticals Business Overview
Table 103. Alnylam Pharmaceuticals Recent Developments
Table 104. GlaxoSmithKline (GSK) Basic Information
Table 105. GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Product Overview
Table 106. GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. GlaxoSmithKline (GSK) Business Overview
Table 108. GlaxoSmithKline (GSK) Recent Developments
Table 109. Ionis Pharmaceuticals Basic Information
Table 110. Ionis Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
Table 111. Ionis Pharmaceuticals RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Ionis Pharmaceuticals Business Overview
Table 113. Ionis Pharmaceuticals Recent Developments
Table 114. Regulus Therapeutics Basic Information
Table 115. Regulus Therapeutics RNA Therapeutics and Vaccines Product Overview
Table 116. Regulus Therapeutics RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Regulus Therapeutics Business Overview
Table 118. Regulus Therapeutics Recent Developments
Table 119. Roche Basic Information
Table 120. Roche RNA Therapeutics and Vaccines Product Overview
Table 121. Roche RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Roche Business Overview
Table 123. Roche Recent Developments
Table 124. AstraZeneca Basic Information
Table 125. AstraZeneca RNA Therapeutics and Vaccines Product Overview
Table 126. AstraZeneca RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Recent Developments
Table 129. Sarepta Therapeutics Basic Information
Table 130. Sarepta Therapeutics RNA Therapeutics and Vaccines Product Overview
Table 131. Sarepta Therapeutics RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Sarepta Therapeutics Business Overview
Table 133. Sarepta Therapeutics Recent Developments
Table 134. Orna Therapeutics Basic Information
Table 135. Orna Therapeutics RNA Therapeutics and Vaccines Product Overview
Table 136. Orna Therapeutics RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Orna Therapeutics Business Overview
Table 138. Orna Therapeutics Recent Developments
Table 139. Global RNA Therapeutics and Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 140. Global RNA Therapeutics and Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America RNA Therapeutics and Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 142. North America RNA Therapeutics and Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe RNA Therapeutics and Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 144. Europe RNA Therapeutics and Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific RNA Therapeutics and Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 146. Asia Pacific RNA Therapeutics and Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America RNA Therapeutics and Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 148. South America RNA Therapeutics and Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa RNA Therapeutics and Vaccines Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa RNA Therapeutics and Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global RNA Therapeutics and Vaccines Sales Forecast by Type (2026-2033) & (K MT)
Table 152. Global RNA Therapeutics and Vaccines Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global RNA Therapeutics and Vaccines Price Forecast by Type (2026-2033) & (USD/KG)
Table 154. Global RNA Therapeutics and Vaccines Sales (K MT) Forecast by Application (2026-2033)
Table 155. Global RNA Therapeutics and Vaccines Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNA Therapeutics and Vaccines Market Size Comparison by Region (M USD)
Table 5. Global RNA Therapeutics and Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global RNA Therapeutics and Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 7. Global RNA Therapeutics and Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global RNA Therapeutics and Vaccines Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics and Vaccines as of 2024)
Table 10. Global Market RNA Therapeutics and Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global RNA Therapeutics and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. RNA Therapeutics and Vaccines Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global RNA Therapeutics and Vaccines Sales by Type (K MT)
Table 26. Global RNA Therapeutics and Vaccines Market Size by Type (M USD)
Table 27. Global RNA Therapeutics and Vaccines Sales (K MT) by Type (2020-2025)
Table 28. Global RNA Therapeutics and Vaccines Sales Market Share by Type (2020-2025)
Table 29. Global RNA Therapeutics and Vaccines Market Size (M USD) by Type (2020-2025)
Table 30. Global RNA Therapeutics and Vaccines Market Size Share by Type (2020-2025)
Table 31. Global RNA Therapeutics and Vaccines Price (USD/KG) by Type (2020-2025)
Table 32. Global RNA Therapeutics and Vaccines Sales (K MT) by Application
Table 33. Global RNA Therapeutics and Vaccines Market Size by Application
Table 34. Global RNA Therapeutics and Vaccines Sales by Application (2020-2025) & (K MT)
Table 35. Global RNA Therapeutics and Vaccines Sales Market Share by Application (2020-2025)
Table 36. Global RNA Therapeutics and Vaccines Market Size by Application (2020-2025) & (M USD)
Table 37. Global RNA Therapeutics and Vaccines Market Share by Application (2020-2025)
Table 38. Global RNA Therapeutics and Vaccines Sales Growth Rate by Application (2020-2025)
Table 39. Global RNA Therapeutics and Vaccines Sales by Region (2020-2025) & (K MT)
Table 40. Global RNA Therapeutics and Vaccines Sales Market Share by Region (2020-2025)
Table 41. Global RNA Therapeutics and Vaccines Market Size by Region (2020-2025) & (M USD)
Table 42. Global RNA Therapeutics and Vaccines Market Size Market Share by Region (2020-2025)
Table 43. North America RNA Therapeutics and Vaccines Sales by Country (2020-2025) & (K MT)
Table 44. North America RNA Therapeutics and Vaccines Market Size by Country (2020-2025) & (M USD)
Table 45. Europe RNA Therapeutics and Vaccines Sales by Country (2020-2025) & (K MT)
Table 46. Europe RNA Therapeutics and Vaccines Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific RNA Therapeutics and Vaccines Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific RNA Therapeutics and Vaccines Market Size by Region (2020-2025) & (M USD)
Table 49. South America RNA Therapeutics and Vaccines Sales by Country (2020-2025) & (K MT)
Table 50. South America RNA Therapeutics and Vaccines Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa RNA Therapeutics and Vaccines Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa RNA Therapeutics and Vaccines Market Size by Region (2020-2025) & (M USD)
Table 53. Global RNA Therapeutics and Vaccines Production (K MT) by Region(2020-2025)
Table 54. Global RNA Therapeutics and Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 55. Global RNA Therapeutics and Vaccines Revenue Market Share by Region (2020-2025)
Table 56. Global RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China RNA Therapeutics and Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Moderna Basic Information
Table 62. Moderna RNA Therapeutics and Vaccines Product Overview
Table 63. Moderna RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Moderna Business Overview
Table 65. Moderna SWOT Analysis
Table 66. Moderna Recent Developments
Table 67. BioNTech (Pfizer) Basic Information
Table 68. BioNTech (Pfizer) RNA Therapeutics and Vaccines Product Overview
Table 69. BioNTech (Pfizer) RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. BioNTech (Pfizer) Business Overview
Table 71. BioNTech (Pfizer) SWOT Analysis
Table 72. BioNTech (Pfizer) Recent Developments
Table 73. Sanofi Basic Information
Table 74. Sanofi RNA Therapeutics and Vaccines Product Overview
Table 75. Sanofi RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Sanofi Business Overview
Table 77. Sanofi SWOT Analysis
Table 78. Sanofi Recent Developments
Table 79. Novartis Basic Information
Table 80. Novartis RNA Therapeutics and Vaccines Product Overview
Table 81. Novartis RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. CureVac Basic Information
Table 85. CureVac RNA Therapeutics and Vaccines Product Overview
Table 86. CureVac RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. CureVac Business Overview
Table 88. CureVac Recent Developments
Table 89. CSL Basic Information
Table 90. CSL RNA Therapeutics and Vaccines Product Overview
Table 91. CSL RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. CSL Business Overview
Table 93. CSL Recent Developments
Table 94. Arrowhead Pharmaceuticals Basic Information
Table 95. Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
Table 96. Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Arrowhead Pharmaceuticals Business Overview
Table 98. Arrowhead Pharmaceuticals Recent Developments
Table 99. Alnylam Pharmaceuticals Basic Information
Table 100. Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
Table 101. Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Alnylam Pharmaceuticals Business Overview
Table 103. Alnylam Pharmaceuticals Recent Developments
Table 104. GlaxoSmithKline (GSK) Basic Information
Table 105. GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Product Overview
Table 106. GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. GlaxoSmithKline (GSK) Business Overview
Table 108. GlaxoSmithKline (GSK) Recent Developments
Table 109. Ionis Pharmaceuticals Basic Information
Table 110. Ionis Pharmaceuticals RNA Therapeutics and Vaccines Product Overview
Table 111. Ionis Pharmaceuticals RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Ionis Pharmaceuticals Business Overview
Table 113. Ionis Pharmaceuticals Recent Developments
Table 114. Regulus Therapeutics Basic Information
Table 115. Regulus Therapeutics RNA Therapeutics and Vaccines Product Overview
Table 116. Regulus Therapeutics RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Regulus Therapeutics Business Overview
Table 118. Regulus Therapeutics Recent Developments
Table 119. Roche Basic Information
Table 120. Roche RNA Therapeutics and Vaccines Product Overview
Table 121. Roche RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Roche Business Overview
Table 123. Roche Recent Developments
Table 124. AstraZeneca Basic Information
Table 125. AstraZeneca RNA Therapeutics and Vaccines Product Overview
Table 126. AstraZeneca RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Recent Developments
Table 129. Sarepta Therapeutics Basic Information
Table 130. Sarepta Therapeutics RNA Therapeutics and Vaccines Product Overview
Table 131. Sarepta Therapeutics RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Sarepta Therapeutics Business Overview
Table 133. Sarepta Therapeutics Recent Developments
Table 134. Orna Therapeutics Basic Information
Table 135. Orna Therapeutics RNA Therapeutics and Vaccines Product Overview
Table 136. Orna Therapeutics RNA Therapeutics and Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Orna Therapeutics Business Overview
Table 138. Orna Therapeutics Recent Developments
Table 139. Global RNA Therapeutics and Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 140. Global RNA Therapeutics and Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America RNA Therapeutics and Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 142. North America RNA Therapeutics and Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe RNA Therapeutics and Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 144. Europe RNA Therapeutics and Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific RNA Therapeutics and Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 146. Asia Pacific RNA Therapeutics and Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America RNA Therapeutics and Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 148. South America RNA Therapeutics and Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa RNA Therapeutics and Vaccines Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa RNA Therapeutics and Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global RNA Therapeutics and Vaccines Sales Forecast by Type (2026-2033) & (K MT)
Table 152. Global RNA Therapeutics and Vaccines Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global RNA Therapeutics and Vaccines Price Forecast by Type (2026-2033) & (USD/KG)
Table 154. Global RNA Therapeutics and Vaccines Sales (K MT) Forecast by Application (2026-2033)
Table 155. Global RNA Therapeutics and Vaccines Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of RNA Therapeutics and Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNA Therapeutics and Vaccines Market Size (M USD), 2024-2033
Figure 5. Global RNA Therapeutics and Vaccines Market Size (M USD) (2020-2033)
Figure 6. Global RNA Therapeutics and Vaccines Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNA Therapeutics and Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global RNA Therapeutics and Vaccines Product Life Cycle
Figure 13. RNA Therapeutics and Vaccines Sales Share by Manufacturers in 2024
Figure 14. Global RNA Therapeutics and Vaccines Revenue Share by Manufacturers in 2024
Figure 15. RNA Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market RNA Therapeutics and Vaccines Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by RNA Therapeutics and Vaccines Revenue in 2024
Figure 18. Industry Chain Map of RNA Therapeutics and Vaccines
Figure 19. Global RNA Therapeutics and Vaccines Market PEST Analysis
Figure 20. Global RNA Therapeutics and Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global RNA Therapeutics and Vaccines Market Share by Type
Figure 27. Sales Market Share of RNA Therapeutics and Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of RNA Therapeutics and Vaccines by Type in 2024
Figure 29. Market Size Share of RNA Therapeutics and Vaccines by Type (2020-2025)
Figure 30. Market Size Share of RNA Therapeutics and Vaccines by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global RNA Therapeutics and Vaccines Market Share by Application
Figure 33. Global RNA Therapeutics and Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global RNA Therapeutics and Vaccines Sales Market Share by Application in 2024
Figure 35. Global RNA Therapeutics and Vaccines Market Share by Application (2020-2025)
Figure 36. Global RNA Therapeutics and Vaccines Market Share by Application in 2024
Figure 37. Global RNA Therapeutics and Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global RNA Therapeutics and Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global RNA Therapeutics and Vaccines Market Size Market Share by Region (2020-2025)
Figure 40. North America RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America RNA Therapeutics and Vaccines Sales Market Share by Country in 2024
Figure 43. North America RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America RNA Therapeutics and Vaccines Market Size Market Share by Country in 2024
Figure 45. U.S. RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada RNA Therapeutics and Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada RNA Therapeutics and Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico RNA Therapeutics and Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico RNA Therapeutics and Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe RNA Therapeutics and Vaccines Sales Market Share by Country in 2024
Figure 53. Europe RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe RNA Therapeutics and Vaccines Market Size Market Share by Country in 2024
Figure 55. Germany RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific RNA Therapeutics and Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific RNA Therapeutics and Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific RNA Therapeutics and Vaccines Market Size Market Share by Region in 2024
Figure 68. China RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America RNA Therapeutics and Vaccines Sales and Growth Rate (K MT)
Figure 79. South America RNA Therapeutics and Vaccines Sales Market Share by Country in 2024
Figure 80. South America RNA Therapeutics and Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America RNA Therapeutics and Vaccines Market Size Market Share by Country in 2024
Figure 82. Brazil RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa RNA Therapeutics and Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa RNA Therapeutics and Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa RNA Therapeutics and Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa RNA Therapeutics and Vaccines Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global RNA Therapeutics and Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America RNA Therapeutics and Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe RNA Therapeutics and Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan RNA Therapeutics and Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China RNA Therapeutics and Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global RNA Therapeutics and Vaccines Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global RNA Therapeutics and Vaccines Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global RNA Therapeutics and Vaccines Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global RNA Therapeutics and Vaccines Market Share Forecast by Type (2026-2033)
Figure 111. Global RNA Therapeutics and Vaccines Sales Forecast by Application (2026-2033)
Figure 112. Global RNA Therapeutics and Vaccines Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of RNA Therapeutics and Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNA Therapeutics and Vaccines Market Size (M USD), 2024-2033
Figure 5. Global RNA Therapeutics and Vaccines Market Size (M USD) (2020-2033)
Figure 6. Global RNA Therapeutics and Vaccines Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNA Therapeutics and Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global RNA Therapeutics and Vaccines Product Life Cycle
Figure 13. RNA Therapeutics and Vaccines Sales Share by Manufacturers in 2024
Figure 14. Global RNA Therapeutics and Vaccines Revenue Share by Manufacturers in 2024
Figure 15. RNA Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market RNA Therapeutics and Vaccines Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by RNA Therapeutics and Vaccines Revenue in 2024
Figure 18. Industry Chain Map of RNA Therapeutics and Vaccines
Figure 19. Global RNA Therapeutics and Vaccines Market PEST Analysis
Figure 20. Global RNA Therapeutics and Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global RNA Therapeutics and Vaccines Market Share by Type
Figure 27. Sales Market Share of RNA Therapeutics and Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of RNA Therapeutics and Vaccines by Type in 2024
Figure 29. Market Size Share of RNA Therapeutics and Vaccines by Type (2020-2025)
Figure 30. Market Size Share of RNA Therapeutics and Vaccines by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global RNA Therapeutics and Vaccines Market Share by Application
Figure 33. Global RNA Therapeutics and Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global RNA Therapeutics and Vaccines Sales Market Share by Application in 2024
Figure 35. Global RNA Therapeutics and Vaccines Market Share by Application (2020-2025)
Figure 36. Global RNA Therapeutics and Vaccines Market Share by Application in 2024
Figure 37. Global RNA Therapeutics and Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global RNA Therapeutics and Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global RNA Therapeutics and Vaccines Market Size Market Share by Region (2020-2025)
Figure 40. North America RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America RNA Therapeutics and Vaccines Sales Market Share by Country in 2024
Figure 43. North America RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America RNA Therapeutics and Vaccines Market Size Market Share by Country in 2024
Figure 45. U.S. RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada RNA Therapeutics and Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada RNA Therapeutics and Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico RNA Therapeutics and Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico RNA Therapeutics and Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe RNA Therapeutics and Vaccines Sales Market Share by Country in 2024
Figure 53. Europe RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe RNA Therapeutics and Vaccines Market Size Market Share by Country in 2024
Figure 55. Germany RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific RNA Therapeutics and Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific RNA Therapeutics and Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific RNA Therapeutics and Vaccines Market Size Market Share by Region in 2024
Figure 68. China RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America RNA Therapeutics and Vaccines Sales and Growth Rate (K MT)
Figure 79. South America RNA Therapeutics and Vaccines Sales Market Share by Country in 2024
Figure 80. South America RNA Therapeutics and Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America RNA Therapeutics and Vaccines Market Size Market Share by Country in 2024
Figure 82. Brazil RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa RNA Therapeutics and Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa RNA Therapeutics and Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa RNA Therapeutics and Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa RNA Therapeutics and Vaccines Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa RNA Therapeutics and Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa RNA Therapeutics and Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global RNA Therapeutics and Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America RNA Therapeutics and Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe RNA Therapeutics and Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan RNA Therapeutics and Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China RNA Therapeutics and Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global RNA Therapeutics and Vaccines Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global RNA Therapeutics and Vaccines Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global RNA Therapeutics and Vaccines Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global RNA Therapeutics and Vaccines Market Share Forecast by Type (2026-2033)
Figure 111. Global RNA Therapeutics and Vaccines Sales Forecast by Application (2026-2033)
Figure 112. Global RNA Therapeutics and Vaccines Market Share Forecast by Application (2026-2033)
